PDB Information

PDB3TZB
MethodX-RAY DIFFRACTION
Host OrganismEscherichia coli
Gene SourceHomo sapiens
Primary Citation
In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-kappa B signaling.
Nolan, K.A., Dunstan, M.S., Caraher, M.C., Scott, K.A., Leys, D., Stratford, I.J.
Mol.Cancer Ther.
HeaderOxidoreductase
Released2011-09-27
Resolution2.190
CATH Insert Date06 Nov, 2011

PDB Images (9)

PDB Prints

PDB Chains (4)

Chain ID Date inserted into CATH CATH Status
A 29 Nov, 2011 Chopped
B 29 Nov, 2011 Chopped
C 29 Nov, 2011 Chopped
D 29 Nov, 2011 Chopped

CATH Domains (4)

Domain ID Date inserted into CATH Superfamily CATH Status
3tzbA00 01 Dec, 2011 3.40.50.360 Assigned
3tzbB00 01 Dec, 2011 3.40.50.360 Assigned
3tzbC00 01 Dec, 2011 3.40.50.360 Assigned
3tzbD00 01 Dec, 2011 3.40.50.360 Assigned

UniProtKB Entries (4)

Accession Gene ID Taxon Description
P16083 NQO2_HUMAN Homo sapiens Ribosyldihydronicotinamide dehydrogenase [quinone]
P16083 NQO2_HUMAN Homo sapiens Ribosyldihydronicotinamide dehydrogenase [quinone]
P16083 NQO2_HUMAN Homo sapiens Ribosyldihydronicotinamide dehydrogenase [quinone]
P16083 NQO2_HUMAN Homo sapiens Ribosyldihydronicotinamide dehydrogenase [quinone]